Abstract:As the world faces the challenge of the COVID-19 pandemic, it has become an urgent need of the hour to understand how our immune system sense and respond to RNA viruses that are often life-threatening. While most vaccine strategies for these viruses are developed around a programmed antibody response, relatively less attention is paid to our innate immune defenses that can determine the outcome of a viral infection via the production of antiviral cytokines like Type I Interferons. However, it is becoming increasingly evident that the "cytokine storm" induced by aberrant activation of the innate immune response against a viral pathogen may sometimes offer replicative advantage to the virus thus promoting disease pathogenesis. Thus, it is important to fine tune the responses of the innate immune network that can be achieved via a deeper insight into the candidate molecules involved. Several pattern recognition receptors (PRRs) like the Toll like receptors (TLRs), NOD-like receptors (NLRs), and the retinoic acid inducible gene-I (RIG-I) like receptors (RLRs) recognize cytosolic RNA viruses and mount an antiviral immune response. RLRs recognize invasive viral RNA produced during infection and mediate the induction of Type I Interferons via the mitochondrial antiviral signaling (MAVS) molecule. It is an intriguing fact that the mitochondrion, one of the cell's most vital organelle, has evolved to be a central hub in this antiviral defense. However, cytokine responses and interferon signaling via MAVS signalosome at the mitochondria must be tightly regulated to prevent overactivation of the immune responses. This review focuses on our current understanding of the innate immune sensing of the host mitochondria by the RLR-MAVS signalosome and its specificity against some of the emerging/re-emerging RNA viruses like Ebola, Zika, Influenza A virus (IAV), and severe acute respiratory syndrome-coronavirus (SARS-CoV) that may expand our understanding for novel pharmaceutical development.

Spatiotemporal dynamics of innate immune signaling via RIG-I–like receptors

Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.

Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5

Mitochondrion: an emerging platform critical for host antiviral signaling

RIG-I-like receptors: their regulation and roles in RNA sensing

Actin cytoskeleton remodeling primes RIG-I-like receptor activation

Mitochondrial Control of Innate Immune Responses

Mitochondria in innate immune signaling

Master sensors of pathogenic RNA - RIG-I like receptors

Regulation of cGAS- and RLR-mediated immunity to nucleic acids

Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors

Mechanisms and Effects of Activation of Innate Immunity by Mitochondrial Nucleic Acids

Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity

High-resolution kinetic characterization of the RIG-I-signaling pathway and the antiviral response

Structural and Functional Insights into 5′-Ppp RNA Pattern Recognition by the Innate Immune Receptor RIG-I

Regulation of antiviral innate immune signaling by stress-induced RNA granules

Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity

A conserved isoleucine in the binding pocket of RIG-I controls immune tolerance to mitochondrial RNA

RIG-I-like receptor DRH-1 signals via CARDs to activate anti-viral immunity in intestinal cells

Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses

Endosomes serve as signaling platforms for RIG-I ubiquitination and activation